[144] Transcat Inc SEC Filing

Rhea-AI Filing Summary

Transcat Inc (TRNS) filed a Form 144 notifying the market of a proposed sale of 10,000 common shares with an aggregate market value of $821,200. The sale is to be executed approximately on 08/26/2025 on Nasdaq. The filing shows the seller acquired underlying shares through a direct purchase (324 shares purchased for cash on 11/05/2012) and vested restricted stock units (50,946 shares vested on 08/20/2019 as equity compensation). The issuer has 9,319,079 shares outstanding per the form. The notice includes the standard representation that the seller is not aware of any undisclosed material adverse information about the issuer.

Positive

• Form 144 disclosure completed, providing market transparency about an insider resale
• Sale size is small relative to outstanding shares (~0.11%), limiting immediate market impact

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine insider sale disclosure; modest size relative to outstanding shares.

The Form 144 documents a proposed sale of 10,000 Transcat common shares valued at $821,200. Against 9.32 million shares outstanding, this represents roughly 0.11% of outstanding stock, indicating a limited direct market impact. The disclosed acquisition sources—small direct purchase and a larger block from vested RSUs—are typical for executive or insider monetization. No information here indicates undisclosed material developments at the company; the seller affirms no such knowledge.

Compliance/Risk Analyst

TL;DR: Filing satisfies Rule 144 notice requirements; no compliance red flags in form content.

The notice contains required elements: class of security, broker, number of shares, aggregate value, approximate sale date, and acquisition history. There are blank fields for some filer/issuer contact details in the provided extract, but the core sale and acquisition disclosures are present. From a regulatory perspective, this appears to be a routine, compliant notification of an intended resale under Rule 144.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab Corp. 3000 Schwab Way Westlake TX 76262	10000	821200.00	9319079	08/26/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/05/2012	Direct Purchase	Issuer			324	11/05/2012	Cash
Common	08/20/2019	Vested Restricted Stock Units	Issuer			50946	08/20/2019	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Transcat Inc's (TRNS) Form 144 say about the number of shares to be sold?

The filing notifies a proposed sale of 10,000 common shares.

What is the aggregate market value of the shares in the TRNS Form 144?

The aggregate market value reported is $821,200.

When is the approximate date of sale listed in the Form 144 for TRNS?

The approximate date of sale is listed as 08/26/2025.

How were the securities acquired that are being sold according to the filing?

The filing shows 324 shares acquired by direct purchase for cash on 11/05/2012 and 50,946 shares from vested RSUs on 08/20/2019 (equity compensation).

How many Transcat shares are outstanding according to the Form 144?

The form reports 9,319,079 shares outstanding.

Does the Form 144 indicate any undisclosed material information about Transcat (TRNS)?

The seller represents by signing the notice that they do not know any material adverse information about the issuer that has not been publicly disclosed.